Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3233
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02286947 | Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy | ||
| NCT01171326 | Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients | ||
| NCT01375985 | Safety Study of Single Administration Intravenous Treatment for Influenza | ||
| NCT04572776 | Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain | ||
| NCT02315638 | Long-Term Follow-Up Safety Monitoring of Patients Dosed in the First-in-Man Phase I/II Study of TT-034. | ||
| NCT02429518 | Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis | ||
| NCT05012189 | Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks | ||
| NCT05475184 | A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor | ||
| NCT04845217 | Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome | ||
| NCT05791474 | ATI-2231 in Advanced Solid Tumor Malignancies | ||
| NCT01601704 | Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study) | ||
| NCT02024152 | Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mg | ||
| NCT03282149 | Preliminary Evaluation of Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain | ||
| NCT02670343 | Phlebotomy Study of Testosterone Undecanoate | ||
| NCT06976268 | A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease | ||
| NCT00244647 | A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis | ||
| NCT01187043 | Determination of the Lowest, Safe and Effective Dose of Proellex | ||
| NCT00511576 | Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors | ||
| NCT00386516 | Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer | ||
| NCT01882647 | A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305) | ||
| NCT02299518 | Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | ||
| NCT03635827 | Xenon Inhalation for Treatment of Posttraumatic Stress Disorder | ||
| NCT00968825 | Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines | ||
| NCT05934513 | A Study of GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) | ||
| NCT03200080 | A Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered Orally in Healthy, Non-Dependent, Recreational Polydrug Users | ||
| NCT03804996 | Study of TG-1801 in Subjects With B-Cell Lymphoma | ||
| NCT02227251 | Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | ||
| NCT03677401 | Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis | ||
| NCT01941836 | Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients | ||
| NCT04535531 | A Phase 3 Molluscum Contagiosum Efficacy and Safety Study | ||
| NCT02540330 | A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant | ||
| NCT00975767 | A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer | ||
| NCT03953092 | A Randomized, Double-blind, Placebo-controlled, Sequential Single and Multiple Ascending Doses of YG1699 | ||
| NCT05853900 | Study of Two Digital Therapeutics for the Prevention of Episodic Migraine | ||
| NCT05103254 | Bempedoic Acid Pregnancy Surveillance Program | ||
| NCT00372437 | A Phase I/II Study of MGCD0103 (MG-0103) in Combination With Gemcitabine | ||
| NCT01991327 | Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy Males | ||
| NCT03487588 | An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses | ||
| NCT00803686 | A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women | ||
| NCT05995405 | Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH | ||
| NCT01800422 | Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer | ||
| NCT03778073 | Study of Cosibelimab in Subjects With Relapsed or Refractory Lymphoma | ||
| NCT07148180 | A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax | ||
| NCT03989362 | Vopratelimab and a CTLA-4 Inhibitor in PD-1/PD-L1 Inhibitor Experienced Subjects With NSCLC or Urothelial Cancer | ||
| NCT05599295 | Study to Evaluate the Safety of Intravenous Oritavancin for the Treatment of Children With Skin Infections | ||
| NCT03815695 | A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients | ||
| NCT02675439 | Safety and Efficacy of MIW815 (ADU-S100) +/- Ipilimumab in Patients With Advanced/Metastatic Solid Tumors or Lymphomas | ||
| NCT01252719 | Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I) | ||
| NCT02750501 | Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study | ||
| NCT06019000 | Study of CYR-064 Versus Placebo in Patients. |
